Ranbaxy Q4 net at Rs 2127 million

Ranbaxy Laboratories Ltd has posted a net profit of Rs 2,127.00 million for the quarter ended December 31, 2002 as compared to Rs 503.00 million in the quarter ended December 31, 2001.

Net sales have increased from 5,699.00 million in DQ-01 to Rs 8,370.00 million in the quarter ended December 31, 2002.

The company has posted a net profit of Rs 6,054.00 million for the year ended December 31, 2002 (FY-02) as compared to Rs 2,533.00 million in the year ended December 31, 2001 (FY-01).

Net sales have increased from Rs 20,262.00 million in FY-01 to Rs 29,249.00 million in FY-02.

Consolidated results are as follows:

The group has posted a net profit of Rs 1,917.00 million in DQ-02. Net sales stood at Rs 11,040.00 million in DQ-02.

The group has posted a net profit of Rs 6,084.00 million for the year ended December 31, 2002 (FY-02) as compared to Rs 2,637.00 million in the year ended December 31, 2001 (FY-01).

Net sales have increased from Rs 27,257.00 million in FY-01 to Rs 38,234.00 million in FY-02.

Commenting

on the business results, D S Brar CEO and managing director, Ranbaxy Laboratories Ltd said, "The results have been very encouraging. We have been able to significantly improve our operational effectiveness and financial performance. A sound base has been established to enter into the specialty products segment in key developed markets."

BSE Code: 500359